Other
Estimated reimbursements to wholesalers and distributors
Moderna Estimated reimbursements to wholesalers and distributors increased by 32.1% to $111M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 38.0%, from $179M to $111M.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2023
Last reportedQ1 2026May 1, 2026
Metric ID:
other_reimbursement_liability_currentHistorical Data
8 periods
| Q4 '23 | Q1 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0 | $119M | $103M | $179M | $118M | $0 | $84M | $111M |
| QoQ Change | — | — | -13.4% | +73.8% | -34.1% | -100.0% | — | +32.1% |
| YoY Change | — | — | — | +50.4% | — | — | -18.4% | -38.0% |
Range$0 – $179M
Avg YoY Growth-2.0%
Median YoY Growth-18.4%
Frequently Asked Questions
- What is Moderna's estimated reimbursements to wholesalers and distributors?
- Moderna (MRNA) reported estimated reimbursements to wholesalers and distributors of $111M in Q1 2026.
- How has Moderna's estimated reimbursements to wholesalers and distributors changed year-over-year?
- Moderna's estimated reimbursements to wholesalers and distributors decreased by 38.0% year-over-year, from $179M to $111M.